Development and validation of an electroanalytical methodology for determination of isoniazid and rifampicin content in pharmaceutical formulations

Development and validation of an electroanalytical methodology for determination of isoniazid and rifampicin content in pharmaceutical formulations

Tuberculosis remains a major public health problem, especially in developing countries. Brazil presents the largest number of cases in Latin America and is among the 22 countries considered priorities by the World Health Organization (WHO). The Rio de Janeiro state has the largest number of cases re...

Full description

Bibliographic Details
Main Authors:	Katia Christina Leandro, Juliana Machado de Carvalho, Luiz Fernando Giovanelli, Josino Costa Moreira
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2009-06-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Isoniazida/determinação Rifampicina/determinação Tuberculostáticos Tuberculose Voltametria de pulso diferencial/utilização Isoniazid Rifampicin Tuberculosis Tuberculostatics Differential pulse voltammetry
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502009000200019

Similar Items

A simple and sensitive method for determination of Norfloxacin in pharmaceutical preparations
by: Zhuo Ye, et al.
Published: (2015-06-01)

Differential pulse voltammetric determination of diclofenac in pharmaceutical preparations and human serum
by: Bilal Yilmaz, et al.
Published: (2015-06-01)

Voltammetric characteristics of miconazole and its cathodic stripping voltammetric determination
by: FRANCISCO C. PEREIRA, et al.
Published: (2002-09-01)

ANÁLISE COMPARATIVA DO DESEMPENHO DE UM SISTEMA DE QPCR IN HOUSE COM INSUMOS NACIONAIS PARA INVESTIGAÇÃO DA RESISTÊNCIA DE CEPAS MYCOBACTERIUM TUBERCULOSIS DROGAS RESISTENTES
by: Wlisses Henrique Veloso de Carvalho Silva, et al.
Published: (2023-10-01)

Mutaciones asociadas con resistencia a rifampicina o isoniazida en aislamientos clínicos de M. tuberculosis de Sonora, México DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico
by: Enrique Bolado-Martínez, et al.
Published: (2012-04-01)

Fatores associados ao abandono da quimioprofilaxia de TB no município de Vitória (ES): um estudo de coorte histórica Factors associated with nonadherence to TB chemoprophylaxis in Vitória, Brazil: a historical cohort study
by: Ethel Leonor Noia Maciel, et al.
Published: (2009-09-01)

Gastric-resistant isoniazid pellets reduced degradation of rifampicin in acidic medium
by: Fátima Duarte Freire, et al.
Published: (2014-12-01)

Avaliação do tratamento com isoniazida em bovinos infectados naturalmente pelo Mycobacterium bovis Evaluation of the treatment with isoniazid carried out in bovines naturally infected with Mycobacterium bovis
by: P.M.P.C. Mota, et al.
Published: (2004-10-01)

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
by: Elias Adikwu, et al.
Published: (2020-01-01)

SIMULTANEOUS CONTENT ANALYSIS OF RIFAMPICIN, ISONIAZID, AND PYRAZINAMIDE IN TABLET DOSAGE FORM BY SPECTROPHOTOMETRY ULTRAVIOLET WITH DWM AND RSM
by: Muhammad Andry, et al.
Published: (2022-11-01)

Nephroprotective Effects of Ficus religiosa Linn (Peepal Plant) Stem Bark against Isoniazid and Rifampicin Induced nephrotoxicity in Albino Rabbits
by: Nadia Hashmi1, Faqir Muhammad1*, Ijaz Javed1, Junaid Ali Khan1, Muhammad Zargham Khan2, Tanweer Khaliq1 and Bilal Aslam1
Published: (2013-07-01)

Mecanismos de acción y de resistencia a rifampicina e isoniacida en Mycobacterium tuberculosis: nueva información sobre viejos conocidos Mechanisms of action of and resistance to rifampicin and isoniazid in Mycobacterium tuberculosis: new information on old friends
by: A. I. De la Iglesia, et al.
Published: (2006-04-01)

Risk estimate of water sources contamination of pesticides (Mancozeb and Carbofuran) in Ventaquemada, Boyacá – Colombia
by: William Roberto Alza Camacho, et al.
Published: (2016-10-01)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates
by: M Hamze, et al.
Published: (2015-01-01)

Fluconazol como alternativa terapéutica en infecciones asociadas a Mycobacterium tuberculosis
by: Sandrea L, et al.
Published: (2018-06-01)

Oral pyridoxine can substitute for intravenous pyridoxine in managing patients with severe poisoning with isoniazid and rifampicin fixed dose combination tablets: a case report
by: M. D. S. A. Dilrukshi, et al.
Published: (2017-08-01)

Protective Effects of Solanium Nigrum Methanolic Extract Against Isoniazid/Rifampicin Induced Hepatotoxicity in Rats
by: Abdel-Hameed M.Fayed, et al.
Published: (2019-10-01)

Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis
by: Mosayeb Rostamian, et al.
Published: (2023-08-01)

Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis
by: I Frésard, et al.
Published: (2011-08-01)

Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity
by: TAIS C. BRITO, et al.
Published: (2014-06-01)

Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
by: Betty R. Mchaki, et al.
Published: (2023-02-01)

Amelioration of isoniazid and rifampicin-induced liver toxicity by Amaranthus graecizans subsp. silvestris in rat
by: Saiqa Ishtiaq, et al.
Published: (2017-09-01)

Hepatoprotective effect of hydromethanol extract of Otostegia integrifolia benth leaves in isoniazid and rifampicin induced Swiss albino mice
by: Endalkachew Gugsa, et al.
Published: (2023-12-01)

Fluconazole as a therapeutic alternative in infections associated with Mycobacterium tuberculosis
by: Lisette Sandrea, et al.
Published: (2018-06-01)

Salários e risco de acidentes de trabalho: evidências de diferenciais compensatórios para a indústria manufatureira
by: Luiz Alberto Esteves
Published: (2008-01-01)

Propuesta de esquemas de tratamiento antituberculosis basados en la susceptibilidad A isoniacida y rifampicina
by: Alberto Mendoza-Ticona, et al.

Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis and the correlation with patient treatment outcomes
by: Zegeye Bonsa, et al.
Published: (2024-02-01)

Resistencia a fármacos antituberculosis en pacientes coinfectados con tuberculosis y virus de la inmunodeficiencia humana, en un hospital de referencia de 2007 a 2010 en Cali (Colombia) Resistance to anti-tuberculosis drugs in patients co-infected with tuberculosis and human immunodeficiency virus from 2007 to 2010 in a reference hospital in Cali (Colombia)
by: David A de Paza, et al.
Published: (2012-09-01)

The protective effect of lycopene against oxidative kidney damage associated with combined use of isoniazid and rifampicin in rats
by: F. Bedir, et al.
Published: (2021-05-01)

Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
by: Lijie Zhang, et al.
Published: (2024-01-01)

High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin
by: Mahamadou Bassirou Souleymane, et al.
Published: (2023-08-01)

Atividade antioxidante de extratos de folhas de ora-pro-nóbis (Pereskia aculeata Mill.) usando métodos espectrofotométricos e voltamétricos in vitro
by: Raquel M. F. Sousa, et al.
Published: (2014-05-01)

Thermal behavior and decomposition kinetics of rifampicin polymorphs under isothermal and non-isothermal conditions
by: Ricardo Alves, et al.
Published: (2010-06-01)

Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review
by: Xiuping Zhuang, et al.
Published: (2022-10-01)

IMPORTÂNCIA DA CORRETA DETECÇÃO DE TUBERCULOSE COM MONORRESISTÊNCIA À RIFAMPICINA
by: Carolini Cristina Valle, et al.
Published: (2023-10-01)

PROFILUL DE SIGURANȚĂ AL MEDICAMENTELOR ANTITUBERCULOASE
by: Lucia ȚURCAN, et al.
Published: (2024-01-01)

Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
by: Chiara Tersigni, et al.
Published: (2021-10-01)

A Simple and Sensitive UPLC–UV Method for Simultaneous Determination of Isoniazid, Pyrazinamide, and Rifampicin in Human Plasma and Its Application in Therapeutic Drug Monitoring
by: Zhimei Jiang, et al.
Published: (2022-04-01)